Detalhe da pesquisa
1.
Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma.
Eur Urol
; 81(6): 555-558, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34980496
2.
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.
Clin Cancer Res
; 28(24): 5405-5418, 2022 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36190432
3.
Determinants of renal cell carcinoma invasion and metastatic competence.
Nat Commun
; 12(1): 5760, 2021 10 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34608135
4.
Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform.
Clin Cancer Res
; 27(17): 4794-4806, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34210685
5.
Pancreatic tropism of metastatic renal cell carcinoma.
JCI Insight
; 5(7)2020 04 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32271170
6.
HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma.
Clin Cancer Res
; 26(4): 793-803, 2020 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31727677
7.
Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder.
Urol Oncol
; 37(7): 478-484, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30910351
8.
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors.
Cancer Discov
; 8(9): 1142-1155, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29884728
9.
Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade.
Cancer Discov
; 7(8): 900-917, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28473526